P2B-068

Sarcoma Oncology Center (Santa Monica, CA) › P2B-068

P2B-068

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
Sarcoma Oncology Center (Santa Monica, CA) · Dr. Reyes
consented 2013-01-10

completed

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 3 nausea with onset in cycle 6 (2013-05-05); assessed as not related to study drug (not related); resolved 2013-05-06.

severe assessed

Grade 2 stomatitis with onset in cycle 3 (2013-03-07); assessed as related to study drug (probable); resolved 2013-03-19.

moderate assessed

Grade 1 thrombocytopenia with onset in cycle 1 (2013-02-02); assessed as related to study drug (probable); resolved 2013-02-12.

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.